Opendata, web and dolomites

StressEBOV SIGNED

Ebola virus manipulation of the cellular stress responses

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 StressEBOV project word cloud

Explore the words cloud of the StressEBOV project. It provides you a very rough idea of what is the project "StressEBOV" about.

summary    cytometric    cell    purification    rig    virus    replicated    cellular    knockout    crispr    drugs    pathogenic    gfp    particles    rnas    ebov    characterised    counteraction    live    unknown    infection    automated    stress    cofactors    entire    western    imagestream    trvlp    granule    therapeutic    severe    11    negative    polymerase    vaccines    proteins    regulation    microscopy    haemorraghic    validated    sgs    image    fusion    treatments    transcribed    genome    viral    people    trvlps    tested    fever    overexpression    mutants    bioid2    flow    interactome    life    nonsegmented    vp35    genetic    panel    proteomic    fundamental    cytoplasmic    poorly    laboratories    firstly    limited    interaction    tagging    pkr    filovirus    sensing    secondly    approved    replication    bsl2    epidemic    ebola    transcription    trap    antiviral    cas9    candidate    co    competent    trigger    latter    depletion    biochemical    vp35biotin    rna    inhibits    africa    treatment    tetracistronic    sensors    counteract    ligase    acquisition    bsl4    cycle    causes    sg    reverse    protein    strand    killed    proximity   

Project "StressEBOV" data sheet

The following table provides information about the project.

Coordinator
KING'S COLLEGE LONDON 

Organization address
address: STRAND
city: LONDON
postcode: WC2R 2LS
website: www.kcl.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://www.kcl.ac.uk/lsm/research/divisions/diiid/departments/infectious/research/neil/lab1
 Total cost 183˙454 €
 EC max contribution 183˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-04-01   to  2019-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KING'S COLLEGE LONDON UK (LONDON) coordinator 183˙454.00

Map

 Project objective

Ebola virus (EBOV) is a highly pathogenic filovirus that causes severe haemorraghic fever and killed over 11,000 people during the recent epidemic in Western Africa. Although potential vaccines and drugs are being tested, no treatment has been approved. Therefore, understanding the cellular regulation of EBOV replication is fundamental to develop novel treatments. EBOV is a nonsegmented negative-strand RNA virus for which research is limited to BSL4 laboratories. However, a recent reverse genetic system using tetracistronic transcription- and replication-competent virus-like particles (trVLPs) allows modelling of the entire EBOV life cycle under BSL2 conditions. The EBOV genome is transcribed and replicated by the viral polymerase complex but the regulation of these processes remains poorly characterised. EBOV RNAs can also trigger antiviral responses via cytoplasmic RNA-sensors RIG-I and PKR, the latter also promoting stress granule (SG) formation. While EBOV inhibits RNA-sensing, the impact of SGs on EBOV is unknown. Therefore, I will investigate the role of cellular stress responses on EBOV replication and their potential counteraction by the EBOV VP35 protein using the trVLP system. Firstly, I will analyse the impact of SGs on EBOV replication by overexpression and CRISPR/Cas9 depletion of SG proteins. Using a panel of VP35 mutants, I will also investigate its potential to counteract SGs by automated flow cytometric image acquisition (Imagestream). Secondly, I will identify the EBOV polymerase complex interactome during infection using two distinct proteomic approaches: co-purification with a VP35-GFP fusion protein(GFP-trap) and VP35biotin-ligase proximity tagging (BioID2). Candidate VP35 cofactors will be validated by biochemical interaction, CRISPR-knockout and live cell microscopy to determine their role in EBOV replication. In summary, this project will increase the understanding of EBOV replication and identify new therapeutic targets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "STRESSEBOV" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "STRESSEBOV" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

LUNG-BIM (2019)

Induction of B cell immunity in the lung mucosa

Read More  

MIRAGE (2019)

Measuring Interstellar Reactions of Aromatics by Gas-phase Experiments

Read More  

INSANE (2020)

Joint Species And Niche Evolution

Read More